Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Addition of Radiation Therapy to Initial Treatment for Extramedullary Acute Myeloid Leukemia Does Not Offer a Survival Benefit When Added to Chemotherapy

Faye M. Feller, MD, Minal Patel, Sean M. Devlin, PhD, Molly Maloy, MA, Martin S. Tallman, MD, Miguel-Angel Perales, MD, Raajit K. Rampal, MD PhD

Blood (2014) 124 (21): 960.

https://doi.org/10.1182/blood.V124.21.960.960

Published: 2014

Journal Articles

Disease-Free Survival in Adult Patients with Acute Leukemia and Advanced CML Supports Use of Double-Unit Cord Blood Grafts As an Immediate Alternative to 8/8 HLA-Matched Unrelated Donors (URD)

Doris M. Ponce, MD, Patrick Hilden, MS, Sean M. Devlin, PhD, Molly Maloy, MA, Marissa N Lubin, BA, H.R. Castro-Malaspina, MD, Jenna D Goldberg, MD, Ann A. Jakubowski, MD PhD, Richard Meagher, PhD, Esperanza B Papadopoulos, MD, Miguel-Angel Perales, MD, Craig S. Sauter, MD, Marcel R.M. van den Brink, MD PhD, James W. Young, MD, Nancy A. Kernan, MD, Richard J O'Reilly, MD, Andromachi Scaradavou, MD, Sergio Giralt, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 2588.

https://doi.org/10.1182/blood.V124.21.2588.2588

Published: 2014

Journal Articles

T-Cell Depleted (TCD) Hematopoietic Stem Cell Transplantation (HCT) For Adult Patients With Acute Myelogenous Leukemia (AML) In First and Second Remission: Long-Term Disease Free Survival(DFS) With a Significantly Reduced Risk Of Graft-Versus-Host Disease(GvHD)

Izaskun Ceberio, MD, Patrick Hilden, MS, Sean M. Devlin, PhD, Molly Maloy, MA, Jenna D Goldberg, MD, Miguel A Perales, MD, Juliet N Barker, MBBS, (Hons), FRACP, Hugo Castro-Malaspina, MD, Guenther Koehne, MD, PhD, Doris M Ponce, MD, Craig S. Sauter, MD, Marcel R.M. van den Brink, MD, PhD, James W. Young, MD, Richard J. O'Reilly, MD, Sergio Giralt, MD, Ann A. Jakubowski, MD, PhD, Esperanza B Papadopoulos, M.D.

Blood (2013) 122 (21): 3387.

https://doi.org/10.1182/blood.V122.21.3387.3387

Published: 2013

Journal Articles

Stem Cell Transplant Versus Chemotherapy in Older Adults with Acute Myelogenous Leukemia In First Remission

Ellin Berman, MD, Molly Maloy, MA, Sean M. Devlin, PhD, Esperanza B Papadopoulos, MD, Ann A. Jakubowski, MD, PhD

Blood (2013) 122 (21): 2146.

https://doi.org/10.1182/blood.V122.21.2146.2146

Published: 2013

Journal Articles

Mutational Profiling Of Myeloid Malignancies For Prediction Of Disease Relapse Following Allogeneic Stem Cell Transplantation

Alan M Hanash, MD, PhD, Sean M. Devlin, PhD, Molly Maloy, MA, Kristina M. Knapp, BS, Vincent A. Miller, MD, Doron Lipson, PhD, Philip J. Stephens, PhD, Geoff A Otto, PhD, Roman Yelensky, PhD, Michelle K. Nahas, PhD, Kai Wang, MD PhD, Ross L. Levine, MD, Marcel R.M. van den Brink, MD, PhD, Ann A. Jakubowski, MD, PhD

Blood (2013) 122 (21): 2096.

https://doi.org/10.1182/blood.V122.21.2096.2096

Published: 2013

NARROW

The Addition of Radiation Therapy to Initial Treatment for Extramedullary Acute Myeloid Leukemia Does Not Offer a Survival Benefit When Added to Chemotherapy

Disease-Free Survival in Adult Patients with Acute Leukemia and Advanced CML Supports Use of Double-Unit Cord Blood Grafts As an Immediate Alternative to 8/8 HLA-Matched Unrelated Donors (URD)

T-Cell Depleted (TCD) Hematopoietic Stem Cell Transplantation (HCT) For Adult Patients With Acute Myelogenous Leukemia (AML) In First and Second Remission: Long-Term Disease Free Survival(DFS) With a Significantly Reduced Risk Of Graft-Versus-Host Disease(GvHD)

Stem Cell Transplant Versus Chemotherapy in Older Adults with Acute Myelogenous Leukemia In First Remission

Mutational Profiling Of Myeloid Malignancies For Prediction Of Disease Relapse Following Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

The Addition of Radiation Therapy to Initial Treatment for Extramedullary Acute Myeloid Leukemia Does Not Offer a Survival Benefit When Added to Chemotherapy

Disease-Free Survival in Adult Patients with Acute Leukemia and Advanced CML Supports Use of Double-Unit Cord Blood Grafts As an Immediate Alternative to 8/8 HLA-Matched Unrelated Donors (URD)

T-Cell Depleted (TCD) Hematopoietic Stem Cell Transplantation (HCT) For Adult Patients With Acute Myelogenous Leukemia (AML) In First and Second Remission: Long-Term Disease Free Survival(DFS) With a Significantly Reduced Risk Of Graft-Versus-Host Disease(GvHD)

Stem Cell Transplant Versus Chemotherapy in Older Adults with Acute Myelogenous Leukemia In First Remission

Mutational Profiling Of Myeloid Malignancies For Prediction Of Disease Relapse Following Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only